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ABSTRACT
Noni (Morinda citrifolia) is a popular medicinal plant of family Rubiaceae. Its
fruit is rich in various phytochemicals and polysaccharides. Anecdotal evidence indicates
that it was used to stimulate the immune system and, thus, to fight various infections.
Limited in vitro studies also support the immunomodulatory role of Noni, however only
one study utilized an animal model. The purpose of this study was to examine the
immunomodulatory properties of Noni fruit the broiler chicken.
Different concentrations of dietary Noni were added to diets and fed to day-old
broiler chickens for 3 to 6 weeks. Gut tissue and blood were sampled to determine the
expression of selected genes, concentration of immunoglobulins and α1-acid
glycoprotein. The results showed that Noni at 6% concentration increased the expression
of Toll like receptor -4 (TLR-4) and TLR-5, chemokine (IL-8), interleukin-12 (IL-12),
and decreased the expression of IL-6 and TLR-7. At 4% concentration, Noni stimulated
the expression of TLR-3. Increased expression of TLR-3, TLR-4 and TLR-5 indicate
antiviral and antibacterial properties of Noni fruits in chickens that are further
strengthened by increased expression of IL-12 and IL-8. Decreased expression of IL-6
indicates anti-inflammatory properties of Noni. However, Noni did not have effects on
serum and gut immunoglobulins or α1-acid glycoprotein concentration. Further
investigations will be necessary to explore the active immunomodulatory ingredients of
Noni and their effects on immunity during viral and bacterial infections.
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CHAPTER I
INTRODUCTION
Herbal and natural products of folk medicine have been used for centuries in
every culture throughout the world. Due to the prohibition of sub-therapeutic use of
antibiotics in food animal industry by some countries, the possibility of a ban in other
countries, and increasing demand for natural products with health benefits, the
importance of medicinal plants have increased in recent years.
Noni (Morinda citrifolia), also known as Indian Mulberry, Ba Ji Tian, Cheese
Fruit and various other names in different countries, is a popular medicinal plant. Its fruit
is rich in a variety of phytochemicals and polysaccharides. Results from limited studies
demonstrated immunomodulatory effects of these constituents in in vitro experiments
(Hirazumi et al., 1996, 1999, Furusawa et al., 2003, Pawlus et al., 2005 Akihisa et al.
(2007). Considering the health benefits of Noni juice, the European Commission of
Health and Consumer Protection accepted it as a novel food (Opinion of the Scientific
Committee on Food on Tahitian Noni® Juice, 2002).
Health is directly related to the immune status of an animal. Gut mucosal
immunity is important in this regards as the gut represents the largest surface area of the
body that contacts with external milieu and thus interacts with diverse chemicals and
infectious or non-infectious agents. Gut mucosa have some unique features to cope with
these antigens. For example, the presence of the microfold cell (M cell) on mucosa
facilitates the uptake of antigen from gut lumen to immune cells, which contain
secondary lymphoid organs (e.g., Peyer’s patches) and thus stimulates the mucosal
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immunity. Also, the total number of lymphocytes present in mucosal surface is greater
than in primary lymphoid organs like spleen and lymph node. Macrophages and dendritic
cells, present in these secondary lymphoid organs, are the first cells that interact with
antigens, primarily via Toll-like receptors, and produce proinflammatory cytokines that
further potentiate the immune response. Other cells, like B-1, of the innate immune
system reside in secondary lymphoid tissue and are responsible for the secretion of
natural antibodies. These antibodies neutralize a broad range of antigens including
polysaccharides. Interestingly, in contrast to adaptive immunoglobulins, the production of
natural antibody does not require T cells or prior exposure to the pathogen.
The purpose of this study was to examine the immunomodulatory properties of
Noni. The study was conducted in two phases. The first experiment determined whether
dietary Noni supplementation enhanced antibody titers, which includes natural
antibodies, during induced inflammation. The second experiment examined the effects of
dietary Noni supplementation on gene expression of Toll-like receptors, proinflammatory
cytokines, and chemokines in gut associated lymphoid tissue as well as systemic and gut
associated antibody production. Supplementation of different concentrations of dietary
Noni fruit puree to broilers, enhanced gene expression of Toll-like receptors, interleukins
and chemokine, however did not effect immunoglobulin concentration. These results
indicate immunomodulatory properties of Noni.
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CHAPTER II
LITERATURE REVIEW
Introduction
The Noni plant is one of approximately 11,000 species of the family Rubiaceae, some
of which are used to treat various diseases. Also known as Indian Mulberry, Ba Ji Tian,
Cheese fruit and various other names in different countries, it is the second most popular
plant used for curative and preventive purposes in Polynesia (Krauss, 1993) as almost all
of its parts in various combinations including root, stem, bark, fruits and leaves have been
used to treat various known acute and chronic diseases in this region for 2000 years
(Whistler, 1985; Bruggnecate, 1992). However, there are no written scientific documents
discussing the ancient use of this fruit as an immunomodulator, even though anecdotal
evidence indicates that it was used to fight various infections and therefore likely
stimulated the immune system (Earle, 2001). The current research focuses on the effect
of the polysaccharides and phytochemicals of Noni on the immue system.

Immunomodulatory Properties of Noni Fruit
The results of recent studies support this role of Noni fruit (Sunder et al., 2007; Li et
al., 2008; Zhang et al., 2009). The nutrient composition and chemical analyses of Noni
fruit suggest that its polysaccharides and phytochemicals have immunomodulatory
effects as evidenced by the results of in vitro experiments (Hirazumi et al., 1996, 1999;
Furusawa et al., 2003; Pawlus et al., 2005; Desai et al., 2009).
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Immunoglobulins and cytotoxic T-cells are the important components of humoral and
cell-mediated immune system, which effectively eliminate the pathogen during infection.
Sunder et al. (2007) first reported the effects of Noni fruit juice on humoral and cellular
immunity. They found that supplementation to broiler chickens of 5% Noni crude fruit
juice in drinking water to 6 weeks of age significantly increased the total antibody titers
against goat red blood cells at 3 weeks of age. However, increment of total antibody titers
does not necessarily reflect the enhancement of immune status as population of certain
types of antibodies are required to neutralize or stimulate complement activation. Cellmediated immunity was measured by response to T-cell mitogen in terms of skin index to
phytohaemagglutinin-P (PHA-P) injection measured 24-h post injection. The response to
PHA-P was to be not found significant. To examine whether Noni-stimulated humoral
immunity provided sufficient protection against infectious diseases, 3-week old broilers
were challenged with infectious bursal disease virus (IBDV), and Noni treatment reduced
approximately 75% mortality. However, it is thought that immunity against IBDV
correlates with antibody titer, but enhancement of cell-mediated immunity is necessary
for protection against the virus which was not affected by Noni in this experiment
(Rautenschlein et al., 2002). Sensitivity of the technique to measure cell-mediated
immunity and provision of Noni juice in drinking water, as only water soluble
compounds were taken by broilers, might be factors that contributed to the lack of
response to Noni treatment. The results of this study provide limited information about
the immunomodulatory effects of Noni on immunity.
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Schafer et al. (2008) utilized dairy calves as an animal model and reported that Noni
fruits have antibacterial properties. Feeding 30 ml of Noni fruit puree twice a day per calf
to newborn calves for up to 2 weeks enhanced bactericidal activities of blood against E.
coli in an in vitro assay. Their findings need to be further investigated as the conclusion
was based on the median differences not the true mean of the data. Based on the results,
these authors hypothesized that the bactericidal activity of Noni may be due to the
modulation of the neonatal immune system. To examine this hypothesis, Brook et al.
(2009) measured the expression of alpha chain (CD25+) of IL-2 receptor on CD8+ and
CD4+ T cells and found increased gene expression of CD25+ on these cells at 3 days of
age. Activated IL-2 receptor transduces cell proliferation signal thus enhance immune
cells population. To check whether the higher expression of this receptor correlated with
the protection against bacterial infection, they supplemented 30 ml of Noni puree every
12 h in Salmonella Dublin and Salmonella Newport infected calves and found a 54%
reduction in total medical treatments per calf as compared to control. This study indicated
the positive correlation of CD25+ with protection against infection, even though enhanced
expression of β and γ subunits are necessary for signal transduction, and these were not
examined. Based on these findings, Darien et al. (2009) determined whether Noni puree
stimulates cell-mediated immunity or humoral immunity. They found that incubation of
0.1 to 10 mg/ml concentration of Noni puree with isolated peripheral blood mononuclear
cells for 4 or 24 h increased the secretion of IL-2, INF-γ, IL-4 and IL-5 in a dose
dependent manner. Interestingly, incubation with Noni puree for 4 h induced a greater
concentration of these cytokines as compared to 24 h incubation. This in vitro study
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indicates that Noni puree potentiated cell-mediated, as well as humoral immunity.
However, for providing the protection against infections it is necessary to examine the
overall outcome of these cytokines in terms of immunoglobulins and different subsets of
effector immue cell populations. Also, IL-4 and INF-γ have antagonizing effects on the
immune response and thus affects the net outcome of immunity.
To examine the possibility of Noni influencing neonatal immunity, the diet of dams
was supplemented with puree, and gene expression was measured in umbilical cord
blood. Noni supplementation during gestation increased gene expressions of Toll-like
receptors (TLRs-1,-2,-4,-5, and 10), interleukins (IL-4, IL-17) and their receptors (IL-4R,
IL-17RA, IL17RB), chemokine (CXCL11), co-stimulator CD27, TNF-α, and Foxp3. It is
interesting that both IL-17 and Foxp3 expression are increased simultaneously, as IL-17
stimulates the innate immune response while Treg cells, which are regulated by Foxp3,
have a suppressive effect on immunity.
Preventive as well as prophylactic treatments of mice with fermented Noni exudate or
its supernatant showed antitumor activity against S180 tumor cells. Fermented Noni
Exudate (fNE) or its supernatant at a dose of 500 µl/day/mouse for 3 days via i.p.
injections increased the percentage of granulocytes and Natural Killer (NK) cells, and
decreased the CD19+ B cells in spleen, peritoneum and peripheral blood of C57BL/7J
mice (Li et al., 2008). These changes in immue responses were positively correlated with
the survival of C57BL/7J mice challenged with S180 tumor cells. However they did not
determine the expression of CD21 on B cells or dendritic cells to examine the
complement modulatory activity of Noni as CD21 binds with the C3d component of
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complement system. Interestingly, similar doses of Noni did not reduce the mortality in
functional NK deficient beige mice. The results indicated that Noni shows anti-tumor
activity via stimulating NK cells. Li et al. (2008) also observed that Noni treatment
increased the duration of survival of thymus (T-cell producing organ) deficient nude mice
but did not influence survivalibility. The suggestion that Noni may also modulate T cells
which may help to eliminate the tumor with NK cells in C57BL/7J mice is supported by
the fact that CD8+ cells are increased in C57BL/7J mice peritoneum. However, they also
showed that Noni enhanced the memory of tumor immunity but they did not compare the
treated data with survived tumor challenged mice from control group. According to the
authors, Noni treatment provided long-term protection; i.e., anti-tumor memory
development. It is not clear whether this was the result of either tumor challenge or Noni
treatment due to insufficient information in control group.
Incubation of pretreated LPS-matured dendritic cells with 1-10% fermented Noni
Exudate (fNE) increased proliferation of syngeneic splenocytes that contain a variety of
immune cells (Zhang et al., 2009). They further examined a subpopulation of splenocytes
and found that B cells and CD4+ T cells increased significantly but that the population of
NK cells and CD8+ cells was unaffected. These in vitro findings are contradicted by the
in vivo findings of Li et al. (2008) that NK cells are increased in number due to fNE
treatment. Proliferation of B cell was not directly stimulated by fNE, but the addition of
immature or LPS matured dendritic cells enhanced B-cell proliferation. The highest
proliferation was found at the fourth day of incubation. However it is conceivable that the
responses to fNE are due to endotoxins such as lipopolysaccharides. The fNE used in the
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study was analyzed and found to contain endotoxins and fNE positive for endotoxins
stimulated proliferation. The proliferative activity was independent of CD-40 of B cells
and required the direct contact between B cells and dendritic cells, and further allowed
these cells to grow up to 3 weeks, resulting in increased IgG and IgM immunoglobulin
concentrations. These findings suggest that fermentated Noni Exudate stimulates the
humoral immune response via stimulating LPS matured dendritic cells or endotoxins in
fNE induce the response.

Immunomodulatory Polysaccharides in the Noni Fruit
Analysis of alcohol precipitated fraction of Noni fruit showed that it contained 80%
pectins and 5% protein-bound arabinogalactans (Bui et al., 2006). Similar purified
polysaccharide fractions isolated from other plant sources exhibited immunological
activities (Luettig et al. 1989; Chintalwar et al. 1999; Lim et al. 2003).
Hirazumi et al. (1996, 1999) studied the effects of polysaccharide rich alcoholic
precipitates of Noni on nitrite production by cultured mice peritoneal macrophage cells
which contribute to bactericidal activity of macrophage. Fractions precipitated by
repeated treatment with ethanol and solubilized in medium enhanced nitrite production.
The same dose of solubilized Noni precipitates when combined with 25 U/ml of INF-γ
exhibited a synergistic effect on nitrite production, which increased fourfold compared to
solubilized precipitates, only. Incubation of different concentrations of precipitates with
isolated human peripheral mononuclear cells for 24 hours increased the IL-1β and TNF-α
production up to 30-250 pg/ml in a dose dependent manner and the relationship was
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linear within the range of 100 to 1000 μg/ml of precipitates. Noni precipitates at 1.25
µg/ml concentration also increased the IL-1β and IL-12 production from mice
macrophage when incubated for 16 and 24 h, respectively. Incubation of similar
concentration of Noni precipitates with splenocytes in the presence of mitogen inhibited
IL-4, enhanced IL-10 production, but had no effect on IL-2 secretion. Similar incubation
experiment with thymocytes increased INF-γ secreation. Polysaccharides of Noni also
exhibited antitumor activity via modulating immune system (Hirazumi et al., 1999).
Prophylactic and therapeutic treatments of Noni precipitates against LLC1 or S180 tumor
cells challenged mice increased survivability and life span. Antitumor activity of Noni
precipitates was abolished with simultaneous treatment of macrophage, NK cells or T cell
inhibitors. Combined with interferon, the antitumor response of precipitates increased
synergistically in both prophylactic and therapeutic treatments (Hirazumi et al., 1999;
Furusawa et al., 2003). These results suggest that Noni polysaccharides stimulate cellmediated immunity, but the researchers did not examine the endotoxin contamination of
Noni precipitates. The procedure did not eliminate the possibility of bacterial growth
during exposure of ripe fruit to sunlight for 1-3 days prior to juice collection and
preparation of precipitate
Peritoneal exudate cells, from mice provided Noni juice at a dose of 100 ml for 15
days, cultured with 3-12 µg/ml concentrations of concanavalin A in the presence of LPS
decreased secretion of IL-4 (Palu et al., 2008). In the same study, incubation of
polysaccharide-rich Noni precipitates with similar cells suppressed INF-γ production.
This observation was contradictory to the finding of Hirazumi et al. (1996, 1999). Palu et
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al. (2008) correlated the immune suppression with increased binding of cannabinoid
receptor-2 (CB-2) to its ligand by Noni fruit juice concentrate but they did not examine
the effect of polysaccharide-rich precipitates on the receptor.
Polysaccharides, hydroalcoholic and aqueous extracts, and alkaloids, and
anthraquinone compounds extracted from the dried Noni fruit powder enhanced the
phagocytic activity of neutrophils in in vitro assay. Oral dosing of these fractions also
increased serum IL-6 in vaccine challenged mice (Nayak et al. 2009).

Immunomodulatory Properties of the Phytochemicals
Phytochemicals refer to the chemicals present in plants, which may or may not be
nutrients, that affect health (Linus Pauling Institute of Micronutrient Research for
Optimum Health). However, limited studies have been examined the effect of Noni fruit
phytochemicals, but similar phytochemicals from the different sources have been
reported to exhibit immunological properties (Table 2.1). The phytochemicals isolated
from the Noni fruit belong to five major classes - iridoids, flavonoids, lignans,
anthraquinones and fatty acid esters. (Wang et al., 1999, 2000; Su et al., 2005; Kamiya et
al., 2004, 2005; Pawlus et al., 2005; Pawlus et al., 2005; Schripsema et al., 2006;
Dalsgaard et al., 2006; Deng et al., 2007; Lin et al., 2007; Zin et al., 2007; Akihisa et al.,
2007 and Nayak et al. 2009).
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Iridoids
Iridoids are terpenes synthesized from two isoprene (2-methyl-1, 3-butadiene)
units and are intermediates in alkaloid biosynthesis. Chemically, iridoids consist of a
cyclopentane ring fused with an oxygen heterocycle (Figure 2.1).

Figure 2.1 Chemical structure of iridoids
Although the iridoids in the Noni fruit have not received much research attention,
studying similar iridoids extracted from different plant sources have shown regulatory
effects on immune cells in an in vitro model. For example, Cimanga et al. (2003)
reported that gaertneroside, which structurally resembles the citrifolinoside of Noni fruit,
inhibited the classical pathway of the complement system. Complement system is a
biochemical pathway that either helps antibodies to eliminate antigen from the body or
directly kill the pathogen. However, this study did not explore the affected component of
complement pathway by the gaertneroside and thus provides limited information of anticomplementary activity of iridoid. It seems that iridoids also check the adverse reactions
of immune cells in the body, since deacetyl asperulosidic acid from Oldenlandia diffusa
inhibited by 64% the oxidation of low density lipoproteins. This is one mechanism by
which these phytochemicals can reduce atherosclerosis due to the oxidation of lipids by
macrophages (Kim et al., 2005). Similarly, Li et al. (2006) reported that asperuloside and
deacetylasperulosidic acid extracted from Lasianthus acuminatissimus, inhibit the
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secretion of TNF-α by cultured mouse peritoneal macrophage cells, with IC50 values of
0.52 and 1 µg/ml, respectively.

Flavonoids
Flavonoids are a group of pigments present in plants. Chemically, flavonoids
consist of two benzene rings linked with either a heterocycle pyran or pyrone ring
(Middleton et al., 2000; Figure 2.2).

Figure 2.2 Chemical structure of flavonoids
Quercetin, kaempferol and catechin isolated from different plants or in a
chemically pure form have been investigated concerning their possible immunological
properties in an in vitro model. The results indicate that quercetin inhibits antigenstimulated histamine release by human basophils and mast cells, over a range of 5 to 50
µM in a dose dependent manner (Middleton et al., 1981; Grossman et al., 1988).
Quercetin also inhibites leukocyte migration, and leukotriene-B4 (LTB-4) and
prostaglandin-E2 (PGE2) concentrations in carrageenan-induced pleural exudates
(Mascolo et al., 1988). In further investigation, these authors found that similar
compounds inhibited the synthesis of ionophore-stimulated leukotriene B4 (LTB-4) in
leukocytes. The phytochemicals, quercetin and kaempferol triglycosides extracted from
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the leaves of Morinda morindoides (of the Noni genus) have been found to exhibit their
anti-complementary activity on the classical and alternative pathways in an in vitro assay
(Cimanga et al., 1995). However, this study did not examine the mechanism by which
quercetin and kaempferol inhibited complement pathways and thus provides limited
information of anti-complementary effects of these phytochemicals.
Flavonoids have also been found to affect cytokine production. Data obtained by
Matsunaga et al. (2001) showed that epigallocatechin gallate reduced production of IL10, while at the same time stimulating production of IL-12 and TNF-α, and stimulating
gene expression of INF-γ by bacterial induced cultured macrophages. Preincubation or
coincubation of the polymeric or dimeric form of catechin or epicatechin reduced nitrous
oxide secretion by stimulated macrophages in a concentration dependent manner, with an
IC50 value of 50 μg/ml (Terra et al., 2007). Similarly, Shim et al. (2008) reported that
epigallocatechin decreased T-cell proliferation and IL-2 secretion by inhibiting the
MAPK and phospholipase-C pathways, via high affinity binding to ZAP-70 kinase (Kd
of 0.6 µM).

Lignans
Lignans are important class of phytoestrogen found in plants. These are
polyphenolic chemicals derived from phenylalanine and monolignols (Figure 2.3,
Checker et al., 2007).
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Figure 2.3 Chemical structure of lignans
Epidemiological studies have suggested that lignans might be helpful in reducing
the risk of breast, ovarian and prostate cancers in humans (Linus Pauling Institute of
Micronutrient Research for Optimum Health). This potential anticancerous property may
be due to their anti-proliferative effect on cancer cells. It appears that lignans may also
suppress proliferation of immune cells. No lignans of Noni fruit have been studied for
their immunomodulatory activities. However, a study conducted by Gredel et al. (2008)
suggested that lignans can suppress the immune system. These researchers found that the
coincubation of 10 µM of matairesinol inhibited the proliferation of peripheral
mononuclear cells. They also reported that matairesinol and secoisolariciresinol had an
inhibitory effect on IL-4, INF-γ and TNF-α secretion by the same cells at 50 µM (Gredel
et al., 2008).

Anthraquinones
Anthraquinones contain two fused benzene rings with an oxygen heterocycle
(Figure 2.4) and are abundantly found in the roots of a variety of plants. Based on mice
and rat studies, conducted by the National Toxicological Program, anthraquinones are
considered to be carcinogens (http://ntp.niehs.nih.gov/files). However, these are
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considered non toxic in Noni fruits, since they are present in a trace amount (Pawlus et
al., 2005).

Figure 2.4 Chemical structure of anthraquinones

For example, under in vitro conditions 0.9 pM concentration of 2-methoxy-1,3,6
trihydroxyanthraquinone extracted from Noni fruit was required to double the activity of
the phase II antioxidative enzyme, quinone reductase, as compared to 0.34 µM of the
positive control L-sulforaphane. Based on these results, the concentration of Noni
anthraquinone required to inhibit 50% of cell growth (ID50) for this compound was 7
times higher than L-sulforaphane. These results indicate that the anthraquinones found in
Noni fruit have extremely low toxic potential and may even have a beneficial effect on
health (Pawlus et al., 2005).

Fatty Acid Esters
The fatty acid esters found in Noni fruit are primarily short chain fatty acids with a
glucopyranose ring (Figure 2.5).
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Figure 2.5 Chemical structure of 6-O-(β-D-glucopyranosyl)-1-O-octanoyl-βglucopyranose
Akihisa et al. (2007) determined the anti-inflammatory effect of fatty acid esters
isolated from Noni fruits by examining of the anti-inflammatory activity of the esters
utilized mouse an animal model. They found that topical application of these esters [2-O(-D-glucopyranosyl)-1-O-octanoyl--D-glucopyranose, 2-O-(-D-glucopyranosyl)-1-Ohexanoyl--D-glucopyranose,

6-O-(-D-glucopyranosyl)-1-O-octanoyl--D-

glucopyranose and 2,6 –di-O(-D-glucopyronosyl)-1-O-octanoyl--D-glucopyronose]
inhibited 12-O-tetradecanoylphorbol-13-acetate (TPA) induced ear inflammation in mice
with ID50 values, of 0.46-0.79 mg per ear.

Miscellaneous Phytochemicals
In addition to these 5 classes of phytochemicals, Noni fruits contain various other
phytochemicals which also have immunomodulatory activities. For example, Su et al.
(2005) found that the glycosidic form of -sitosterol palmitate showed strong anticomplementary activity against the classical pathway in an in vitro assay with IC50 of
1µM. This concentration was approximately 77 times lower than the control (Yoon et al.,
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2005). In further research, Desai et al. (2009) studied the effect of this phytochemical on
immune cells, reporting that a 4 µM concentration of β sitosterol inhibited the release of
IL-10 secretions from peripheral blood mononuclear cells isolated from multiple sclerosis
patients compared to healthy individuals. However, it enhanced IL-10 secretion and
reduced the proliferation of peripheral blood mononuclear cells isolated from healthy
individuals at the same concentration compared to control.
In addition, vanillin (4-hydroxy-3-methoxybenzaldehyde) detected in the alcoholic
extracts of Noni fruit inhibited carrageenan-induced paw edema of rats in a dose
dependent manner, ranging from 12.5 mg/kg to 50 mg/kg per os. This inhibitory effect
was correlated with the antioxidative activity of the compound in an in vitro assay (Lee et
al., 2006). Similarly, Murakami et al. (2007) demonstrated that 100-500 μM
concentrations of vanillin were potent inhibitors of LPS-stimulated cyclooxygenase-2
(COX-2) expression in macrophages.

17

Table 2.1 Noni fruit phytochemicals and their biological activities

Compounds
Iridoids
Asperuloside
Deacetylasperulosidic
acid
Flavonoids

Quercetin

Kaempferol
triglycosides
Catechin

Immunomodulatory Properties of Noni Fruit
Immune AntiAntiAntiresponse complementary
inflammatory
oxidation
-

+

-

+

-

+

+

+

+
-

References
Li et al. (2006)
Kim et al. (2005)
Li et al. (2006)
Middleton et al. (1981)
Cumella et al.(1987)
Grossman et al. (1988)
Mascolo et al. (1988)
Aviram et al. (1998)
Cimanga et al. (1995)
Cimanga et al. (1995)
Terra et al. (2007)
Matsunaga et al. (2002)
Shim et al. (2008)

Epigallocatechin
Lignans
3,3’
bisdemethylpinoresin
ol
Americanol A
Americanin A
Americanoic acid A

Kamiya et al. (2004)
+
+

Anthraquinones
2-methoxytrihydroxyanthraquin

+
+
+

+
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Kamiya et al. (2004)
Kamiya et al. (2004)
Kamiya et al. (2004)
Pawlus et. al. (2005)

one
Fatty Acid Ester
Miscellaneous
Β sitosterol

-/+

+

Akihisa et al. (2007)

+

Vanillin

+

+

Yoon et al. (2005)
Desai et al. (2009)
Lee et al. (2006)
Murakami et al. (2007)

Note: + and – sign and indicates the stimulatory and inhibitory effects on the response or activity. +/sign indicates both effects.
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CHAPTER III
EFFECTS OF DIETARY NONI SUPPLEMENTATION ON IMMUNE
RESPONSES AFTER LPS CHALLENGE IN BROILERS
Materials and Methods
Animals and Husbandry
Day-old broiler chicks were obtained from a commercial hatchery. Chicks were
provided with free access to water and practical corn-soy diet during the experiment. All
procedures with chickens were approved by Clemson University Institutional Animal
Care and Use committee.

Experimental Design and Dietary Treatments
The study was conducted using 108 day-old commercial broiler chickens
distributed at random to 18 wire-floor pens (six birds per pen). A practical corn-soy diet
was supplemented with either 0, 1 or 2% (w/w) concentrations of Noni crude fruit
preparation to determine the minimum dose requirement of Noni that modulates
immunity (Whole Noni fruit puree, 047-058-01, Morinda Agriculture Products Inc.,
Utah), and the three dietary treatments were assigned at random to the 18 pens to provide
replications per treatment (n=6). The diets were fed from day-old to the 21 days of age.
At 21 days of age, two pairs of birds were randomly selected from each pen, and each
pair treated with either 2% lipopolysacchride (LPS) (L 7261, Sigma-Aldrich, St. Louis,
MO) dissolved in normal saline or normal saline at 2mg/kg via intraperitoneal (i.p.) route.
Blood and tissue samples were collected at 6 h and 24 h post LPS challenge.
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Sample Collection
To assess the systemic immunoglobulin concentration and serum α1-acid
glycoprotein, blood samples were collected via cardiac puncture of birds at 6 and 24
hours after LPS challenge. Serum was separated by centrifugation at 500 X g for 30
minutes and stored at -4

0

C until further analysis. For detection of gut tissue

immunoglobulins, approximately 1 centimeter length of the gut tissue, along with its
content, was cut from right side of Meckel‘s diverticulum (towards the ceca) after
opening the abdominal cavity of the birds aseptically, and was stored at -800 C until
further analysis. Feed consumption, body weight, liver, spleen, and bursa weights were
also recorded.

Serological and Gut Tissue Analysis
Serum IgA, IgM and IgG, and intestinal IgA antibodies were estimated by a
sandwich enzyme-linked immunosorbent assay (ELISA) using kit (E30-102,-103,-104,
Bethyl Laboratories, Montgomery, TX). Briefly, 96-well flat bottomed microtiter plates
(01-010-3855, Dynatech, Chantilly, VA) were coated with 100 µl of a 1:100 dilution of
goat antichicken IgG in coating buffer (0.05 M carbonate-bicarbonate buffer, pH 9.6) and
incubated for 1 h. Plates were then washed five times with wash solution (50 mM Tris,
0.14 M NaCl, 1% BSA, 0.05% Tween 20, pH 8.0) and blocked for 30 minutes using 200
µl of blocking buffer (50 mM Tris, 0.14 M NaCl, 1% BSA, pH 8.0) to avoid non-specific
binding on well surface. After washing, 100 µl of diluted serum (1: 20000, 1: 10000 and
1: 5000 times for IgG, IgM, and IgA, respectively) in sample diluent (50 mM Tris, 0.14
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M NaCl, 0.05%Tween-20, 1% BSA, pH 8.0) and gut tissue supernatant in phosphate
buffer saline (1:200) were then added and plates were incubated for 1 h. All samples were
added in duplicate. Blanks (no test sample) and serial dilutions of chicken IgG, IgM or
IgA standards were also included on each plate. Samples, those absorbance values were
above than upper limit of standards’ absorbances or that had more than 10% variations in
absorbance between duplicates were run again. Standards were run in each plate.
Following incubation, plates were washed 5 times with wash solution and subsequently,
100 µl horseradish peroxidase conjugated chicken IgG, IgM or IgA detection (diluted 1:
10000 in sample diluents) antibodies were added and incubated for 1 h. After incubation,
plates were washed five times with wash solution and 100 µl of substrate, ABTS [2, 2’ –
azino-bis (3- ethylbenzthiazoline-6-sulfonic acid)], was then added and plates were
incubated for 15 minutes. The absorbance was measured at 405 nm using a microplate
reader (Thermomax model 1989) and calculated concentration using standard curve. All
procedures were done at room temperature. The minimum detection limit of ELISA essay
for IgA, IgG and IgM immunoglobulins were 15.625, 3.12, and 3.9 ng/ml, respectively.
Intestinal IgA was extracted as described by Haghighi et al (2005), (Appendix 1), and
results were expressed in terms of total soluble protein measured by the bicinchoninic
acid (BCA) method (232-23,-24, Thermo Scientific, Rockford, IL). Serum α1- acid
glycoprotein (AGP) was measured by chicken α1- acid glycoprotein measurement kit
(P0801-1, The Institute for Metabolic Ecosystem, Miyagi, Japan). Briefly, plates with
chicken anti-AGP antibody in agarose were used to measure AGP concentration by radial
immunodiffusion assay. Five microliter test sample was applied to individual wells in
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plate. Chicken AGP standards were also applied to each plate and the plate placed in a
humidified chamber at 370 C to incubate for 48 h. After incubation, outer diameter of
each precipitin ring was measured and AGP concentration was calculated using the
standard curve.

Statistical Analysis
Data collected were subjected to analysis of variance (ANOVA) using the general
linear model procedure (GLM) of SAS (Version 9.1, SAS, Cary, NC). Response
variables were analyzed using the CRD linear model, Yij = μ + αi + eij, where Y ij =
variable measured; μ= overall mean; αi = the effect of ith level of dietary treatment; eij =
random error for Jth pen receiving ith level of dietary treatment. Hartley's Fmax test was
used to examine homogeneity of variance assumption. The difference between LPS
challenge and control for each pen constituted the response variable in the case of organ
weights, serum and gut immunoglobulins, and α1-acid glycoprotein.
Orthogonal polynomial contrasts were used to examine relationships between
response variables and dietary levels of Noni. Hypothesis tests for linear and quadratic
responses were examined using α = 0.05.
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Results
Results showed that performance in terms of body weight, feed conversion ratio
and livability, and organ weights were not affected by Noni (P>0.05; all contrasts) (Table
3.1). Dietary Noni did not affect serum IgG, IgM and IgA, and gut IgA concentrations
after 6 h or 24 h post LPS challenge (P>0.05; all contrasts) (Table 3.2 and 3.3). A
statistically significant departure from linearity was detected in serum IgM 24 hours post
LPS challenge (P< 0.05) (Table 3.3). Serum IgA 24 h post LPS challenge exhibited a
trend in deviation from linearity (P = 0.07) (Table 3.3). Linear or non-linear (quadratic)
relationship was insignificant between other response variables and levels of Noni at 6 h
or 24 h (P>0.05) (Table 3.1, 3.2 and 3.3)
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Table 3.1 Performance and relative organ weights of broiler chicks fed dietary Noni from day-old to 3 weeks of age

Diet1
(%Noni)

25

0
1
2
± SEM
Linear
Quadratic

Body
weight
(g)
3

805
811
794
9.1
0.52
0.36

Feed
conversion
(g/g)
1.28
1.26
1.29
0.010
0.94
0.38

Liver2
(g/g)
6h
0.11
0.19
0.01
0.10
0.60
0.96

Spleen2
(mg/g)
24 h
0.26
0.27
0.23
0.24
0.89
0.35

6h
0.026
0.002
0.182
0.009
0.75
0.06

24 h
0.020
0.032
0.002
0.015
0.35
0.89

Bursa2
(mg/g)
6h
-0.068
-0.049
-0.022
0.043
0.33
0.90

24 h
0.010
-0.045
-0.014
0.033
0.46
0.64

1

Noni animal feed supplement (Morinda®) added to the diet (w/w). Survival was 100% for all diets

2

The relative organ weights are expressed as the mean difference between birds challenged with lipopolysaccharide (2
mg/ kg body weight, i.p.) and controls that received saline measured at 6 and 24 hours post challenge.
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Table 3.2 Immune responses of broiler chickens fed dietary Noni from day-old to 3
weeks of age 6 h post LPS challenge.
Diet1
(%Noni)
0
1
2
± SEM

Serum α- acid
Glycoprotein2
(µg/ml)
793
66
20
31.8

Linear
Quadratic

0.15
0.23

Serum Immunoglobulin2
(mg/ml)
IgM
IgG
IgA
0.14
0.45
0.03
0.16
0.60
-0.28
-0.01
0.62
-0.11
0.24
0.26
0.15
P value
0.28
0.40
0.49
0.12
0.26
0.73

Intestinal IgA2
(ng/mg protein)
-510
-636
262
546
0.57
0.33

1

Noni animal feed supplement (Morinda®) added to the diet (w/w).

2

The response variables are expressed as the mean difference between birds
challenged with lipopolysaccharide (LPS, 2 mg/ kg body weight, i.p.) and controls that
received saline measured at 6 hours post challenge.
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Table 3.3 Immune responses of broiler chickens fed dietary Noni from day-old to 3
weeks of age 24 h post LPS challenge.
Diet1
(%Noni)
0
1
2
± SEM

Serum α- acid
Glycoprotein2
(µg/ml)
2183
311
347
126

Linear
Quadratic

0.44
0.82

Serum Immunoglobulin2
(mg/ml)
IgM
IgG
IgA
0.30
-1.88
0.01
0.13
-0.19
-0.18
0.40
0.58
-0.22
0.18
1.17
0.12
P value
0.28
0.19
0.12
0.05
0.97
0.07

Intestinal IgA2
(ng/mg protein)
-379
147
31
189
0.60
0.94

1

Noni animal feed supplement (Morinda®) added to the diet (w/w).

2

The response variables are expressed as the mean difference between birds
challenged with lipopolysaccharide (LPS, 2 mg/ kg body weight, i.p.) and controls that
received saline measured at 24 hours post challenge.
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Discussion
In the present study, concentration of dietary Noni at 1% and 2% did not
influence performance and immune responses in broiler chickens. The only significant
response was a departure from linearity in serum IgM 24 hours post LPS challenge and a
trend in deviation from linearity for serum IgA 24 hours post LPS challenge. The former
is due to the lack of response to LPS challenge in birds fed 1% Noni and the latter due to
non-responsiveness to LPS challenge in birds fed 1 or 2% Noni.
Many factors can influence the determination of humoral immune response
against LPS in chickens fed dietary Noni. Genetic differences in breeds (Van der Zijpp et
al., 1983; Kundu et al., 1999) and lines (Kundu et al., 1999; Hangalapura et al., 2003;
Parmentier et. al., 2004) of meat and layer chickens are associated with differences in
natural or specific antibody (NAb) response. This finding is strengthened by the fact that
at the molecular level, the distribution of Toll-like receptor-4 (TLR-4) is dependent on
the genetic make-up of the birds (Dil et al., 2002). However, it is assumed that broilers
are genetically similar due to selective line breeding, though, the production of NAb
against different or same antigens is affected by linkage between the genes or by geneticenvironmental interaction, for example, different quantitative trait loci are associated with
natural antibody responses against LPS in chicken (Siwek et al., 2006). Along with
genetics, significant individual variation within treatment groups for gut IgA immune
response may be ascribed to variability in the location of IgA producing B-cell rich
Peyer’s patches within the chicken intestine. The sampling procedure may result in
samples with little or no Peyer’s patches.
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The present experiment was designed to examine the effect of dietary Noni at 3
weeks of age in chickens as GALT (Gut Associated Lymphoid Tissue) is fully functional
two weeks post-hatching in broilers (Shira-Bar et al., 2003). Further, Lactobacillus
species in broiler chickens are present predominantly in the small intestines at two weeks
of age while some obligatory anaerobes become prominent in the ceca at 25 days of age
(Romach et al., 2004). However, the number of CD3+ T cells continue to increase to 4-6
weeks of age (Lillehoj et al., 1992) and the level of NAb in serum increases from 5 to 18
weeks of age in layers (Siwek et al., 2006). These factors may contribute to both
individual variation and response of variables measured.
Levels of maternal antibodies transferred to the chicks are directly related to the
dam’s circulating concentration of antibodies (Hamal et al., 1996), which may differ
among dams due to differences in genetic make-up; also, carry-over antibodies may
persist up to 25-27 days in chicks and contribute to individual variation in antibody titer
(Mahmud et al., 2007). Hence, serum IgG response in the study may have been affected
by maternal antibodies. In addition to these factors, the limits of detection of the ELISA
assay may also be a factor that contributes to failure to detect the effect of Noni on NAb
as the detection limit of ELISA essay for IgA, IgG and IgM immunoglobulins were
15.625, 3.12, and 3.9 ng/ml, respectively.
To date, the exact function of non-specific NAb in not clear, and it seems that it is
less important in domesticated species of birds. Natural immunity was found to be lower
in commercial layers as compared to their wild ancestor, Red Jungle Fowl (Mekchey et
al., 1999). Hence, in addition to a follow-up study to examine gene expression, the effect
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of dietary Noni on vaccine-induced specific immunity against a commercially important
specific viral or bacterial disease is warranted.
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CHAPTER IV
EFFECTS OF DIETARY NONI SUPPLEMENTATION ON GENE EXPRESSION
AND IMMUNOGLOBULINS IN BROILERS
Materials and Methods
Experimental Design and Dietary Treatments
Day-old commercial broiler chicks were distributed at random in wire-floor pens.
A pen of six birds was the experimental unit. A practical diet was supplemented with 0, 4
and 6% (w/w) concentrations of Noni crude fruit preparation (whole Noni fruit puree, Lot
# 051-011-16, Morinda Agriculture Products Inc., Utah) and fed for 42 days. Treatments
were assigned at random to 3 pens to provide 6 replications per treatment (n=6). At day
42, birds from each pen were sampled for blood and tissue collection. To avoid the loss
of phytochemicals, the Noni puree was stored at -4 0C and mixed in the diet on alternate
days during the experiment.

Sample Collection
To assess gene expression of cytokines, chemokine and Toll-like receptors, cecal
tonsils were collected from both sides of the ileocecal junction (Appendix B). Blood
samples were collected from cutanea ulnaris of the birds. Serum was separated from
sampled blood by centrifugation at 500 X g for 30 minutes and stored at -4 0C till further
analysis. For determination of gut IgA, a 6-cm portion of intact distal ileum (with
contents) (approximately 5 cm cranial from the iliocecal junction) was sampled, placed in
liquid nitrogen during collection and then stored at -800 C until further analysis. The
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mucosal scraping along with gut content of the intestine was used to determine the
concentration of immunoglobulins.

Serum and Gut Immunoglobulins Analysis
Serum IgM and IgG, and gut (mucosal and luminal) IgA antibodies were
estimated by using ELISA assay kit (L30-102,-103,-104, Bethyl Laboratory,
Montgomery, TX). Intestinal IgA was extracted from gut content and mucosal scrapping
as described by Haghighi et al. (2005) (Appendix A). The absorbance results were
expressed in terms of total soluble protein measured by bicinchoninic acid (BCA) method
(232-23,-24, Thermo Scientific, Rockford, IL).

RNA Isolation, Quantification and Real-Time PCR
Total RNA was isolated from the right cecal tonsil of each sample using RNeasy
protect mini kit (74124, Qiagen Inc., Valencia, CA) as described in Appendix C. RNA
was quantified at 260 nm wavelength (Eppendorf, Hamburg, Germany) and samples with
mRNA purity of about 1.8 (ratio E260/E280) or above 1.8 (ratio E260/E280) were used.
Contaminating DNA was digested using the RNase free DNase set (79245, Qiagen Inc.,
Valencia, CA) during RNA extraction and resulting RNA eluted in 50 µl RNase-free
water per 30 mg tissue and stored at -80 O C. Real-Time PCR (QPCR) was done using the
QuantiTechTM SYBR Green one step RT-PCR Kit (204243, Qiagen Inc., Valencia, CA)
and a BIO-RAD thermocycler (Model IQ5), as described in Appendix D. QuantiTect
SYBR Green RT-PCR master mix containing reverse transcriptase together with the
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QuantiTect RT Mix containing DNA polymerase allow both reverse transcription and
amplification of transcript in a single tube. No-RNA template control and melting curve
of gene specific PCR product were analyzed to cross check the primer dimer formation.
No-RT control reaction was used to ensure the amplification of gene specific PCR
product. The gene specific primers used for PCR are listed in appendix F.

Semi-Quantitative RT-PCR and Gel Electrophoresis
RT-PCR was done using ProtoScript M-MuLV Taq RT-PCR kit (E6400S, New
England Biolab, Ipswich, MA) and BIO-RAD thermocycler (Model MJ mini, according
to Appendix E). Two and one half microgram of total RNA was used for reverse
transcription reaction, using 10 units of Moloney murine leukemia virus reverse
transcriptase (RT), 2 µl of RT buffer, 2 µl of 50 µM oligo dT primer, 20 units of murine
RNase inhibitor, 500 µM of dNTP in a reaction mix of 20 μl RNase free water. Reverse
transcription was performed to convert mRNA to cDNA at 42 oC for 60 minutes and 80
o

C for 5 minutes.
PCR reaction were performed in a volume of 50 µl containing 2.5-5 µl of cDNA

from the reverse transcriptase reaction, 200 nanomoles of each primer, 10 mM Tris-HCl
(pH 8.6), 50 mM KCl, 1.5 mM MgCl2 , 200 µM dNTP, 0.05 % Tween-20, 5% glycerol
and 1.25 units of Taq DNA polymerase. Before the start of the first cycle, all PCR were
preceded by a denaturation step of 1 minute at 94 oC and the last cycle step was followed
by a final elongation step of 10 minutes at 68 oC. Thirty five cycles were used for IL-8
and TLR-7 assays and 40 cycles were applied for IL-12 assay. The number of cycles was
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optimized to prevent the amount of PCR product from exceeding the upward slope of a
typical cycle number-PCR product. The gene specific primers used for PCR reactions
were similar to Real-Time PCR primers. Each PCR cycle contained denaturation at 94 oC
for 30 seconds, annealing at 57 oC for 30 seconds and elongation at 68 oC for 60 seconds.
Gene specific PCR products was separated in 1.5% agarose gels (32803, USB, Cleveland,
OH) using 0.02% ethidium bromide for visualization. Band intensity was examined in
ultraviolet light using an illuminometer and quantified using Image J software
(www.rsb.info.nih.gov).

Real-Time Data Analysis
The data obtained from the QPCR, was analyzed using cycle number (Ct values).
The cycle number at which the fluorescence crosses an arbitrary line called the threshold
(i.e. when the fluorescence signal becomes detectable) is known as Ct value. Following
treatment with 4% or 6% dietary Noni supplement, relative fold change of mRNA for the
gene of interest was determined as described by Pfaffl (2001), using equation 1. The
initial RNA concentration was same for all samples and adjusted by diluting in RNase
free water before performing Real-Time PCR.

(1 + E Target) ΔCt, Target
Fold expression =

(1)
(1 + E GAPDH, Control) ΔCt, GAPDH

where,
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Δ Ct, Target = (Ct, Target, Control - Ct, Target,

Noni treatment)

and Δ Ct, GAPDH = ( Ct,GAPDH, Control - Ct, GAPDH,

Noni treatment)

PCR efficiency of the target and reference gene was calculated by plotting the log of the
RNA template dilution versus Ct value using the following equation:

E =10- (1/s) – 1

(2)

where s represents the slope of the line plotted for log of the template dilution versus log
of Ct value. Standard curves were generated using 5 fold serial dilution of total cellular
RNA from broiler chickens. Total cellular RNA used ranged from 200 ng to 12.5 ng. The
efficiency of standard curves were listed in Table 4.1
Table 4.1: Description of standard curves used in data analysis.
Gene of Interest
GAPDH
IL-1β
IL-6
IL-8
IL-12
TLR-3
TLR-4
TLR-5
TLR-7

Efficiency
0.93
1.10
1.08
0.90
1.23
0.94
1.24
1.69
1.12

R2
0.99
0.99
0.99
0.98
0.94
0.98
0.99
0.90
0.93

Statistical Analysis
ANOVA was performed using the general linear model (GLM) procedure of JMP
statistical software (SAS Institute Inc., Cary, NC, USA), and hypothesis testing was
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conducted using α = 0.05. Response variables were analyzed using the following linear
model:
Yij = μ + αi + eij, where Y ij = variable measured; μ= overall mean; αi = the effect of ith
level of dietary treatment; eij= random error associated with experimental unit.
Normalized values of response variables were taken for statistical analysis.
Normalization was done by dividing the Ct value of gene of interest to that of Ct value of
internal control (GAPDH) of the sample.
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Results
The objective of this experiment was to investigate the effects of dietary Noni
crude fruit extract on target gene expression in broiler chickens. Genes included
cytokines, chemokine, and Toll-like receptors in cecal tonsil, and immunoglobulin
concentrations. Gel electrophoresis of PCR product showed the modulatory effects of
Noni on IL-8, IL-12 and TLR-7 gene expression (Figures 4.1). Further analysis by Real time PCR reveled that 4% Noni treatment increased (1.9 fold) TLR-3 gene expression.
However did not show any effect on the expression of other genes (Figure 4.2). Noni at
6% inclusion increased the expression of IL-8 (3 fold), IL-12 (4 fold) and TLR-4 (2.6
fold), and decreased gene expression of IL-6 (0.6 fold) and TLR-7 (0.3 fold) (Figure 4.3).
TLR-5 gene expression was increased 1.7 and 2.3 fold by 4% and 6% Noni, respectively
(Figures 4.2 and 4.3). Neither concentrations of Noni affected IL-1 gene expression
(Figures 4.2 and 4.3). The values of coefficient of determination (R2) of standard curve
for TLR-7, TLR-5 and IL-12 genes were 0.93, 0.90 and 0.94, respectively (Table 4.1)
which were less as than R2 values obtained for other measured genes (0.98-0.99) (Table
4.1). Dietary Noni supplementation did not have significant effects on the concentration
of serum IgM and IgG or intestinal IgA (Table 4.2)
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Table 4.2 Immune responses of broiler chickens fed dietary Noni from day-old to 6
weeks of age
Diet1
(%Noni)
0
4
6
± SEM

Serum Immunoglobulin2
(mg/ml)
IgM
IgG
0.30
1.32 ± 0.25
0.25
1.47
0.36
1.42
0.05
0.22

Gut Immunoglobulin2
(% Total protein)
IgA
2.89
1.91
2.52
0.60

1

Noni animal feed supplement provided by Morinda®, was supplemented to the diet
as w/w basis and fed from day-old to 6 weeks of age.

2

Each pooled mean based on 5 samples except serum IgG in control group where
pooled mean is based on 6 samples.

38

Control

6% Noni

(A)

Gene expression (% of GAPDH)

180
160
140
120
100

Control
6% Noni

80
60
40
20
0
IL-12

IL-8

TLR-7

(B)
Figure 4.1 Effect of 6% dietary Noni supplement on gene expression in caecal tonsil of
broilers fed to 6 weeks of age starting from day-old chicks using semi quantitative RTPCR. Gel electrophoresis was performed (Panel A). The band densities of gene specific
PCR products were quantified using Image J software (http://rsb.info.nih.gov/ij/) and
expressed as a percentage of their respective internal control GAPDH (Panel B).
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Relative fold change

200

0.06

0.41

150

0.67

0.25
0.32

100

0.35

50

0.51

0.1

0
Control

IL-1

IL-6

IL-8

IL-12

TLR-3

TLR-4

TLR-5

TLR-7

Figure 4.2 Effect of 4% dietary Noni supplement on gene expression in caecal tonsil of
broilers fed to 6 weeks of age using Real-Time PCR.
P values are presented above the bar and P< 0.05 indicates the significant difference
from the control group. Data are presented as mean of 5 samples (n=5)
Gene expression of treatment group is expressed relative to control group according to
Pfaffl (2001) method.
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450

0.008

Relative fold change
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0.74
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0.003
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IL-6

IL-8

IL-12
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TLR-4

TLR-5

TLR-7

Figure 4.3 Effect of 6% dietary Noni supplement on gene expression in caecal tonsil of
broilers fed to 6 weeks of age using Real-Time PCR.
P values are presented above the bar and P< 0.05 indicates the significant difference
from the control group. Data are presented as mean of 5 samples (n=5)
Gene expression of treatment group is expressed relative to control group according to
Pfaffl (2001) method.
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Discussion
The observed increased TLR-3, TLR-4, IL-8 and IL-12 gene expression and
decreased IL-6 and TLR-7 gene expression in gut associated caecal tonsil in chickens fed
dietary Noni indicated that Noni crude fruit extracts have immunomodulatory properties.
The immunomodulatory property of Noni fruit is supported by some in vitro studies
(Hirazumi et al., 1996, 1999; Furusawa et al., 2003; Li et al., 2008; Zhang et al., 2009;
Brooks et al., 2009). For example, Noni fruit polysaccharides increased IL-1 and TNF-α
secretion from human peripheral mononuclear cells in a dose dependent manner
and fermented Noni juice pretreated dendritic cells increased immunoglobulin secretion
from B cells ((Hirazumi et al., 1996, Zhang et al., 2009)
Noni fruit is rich in phytochemicals and polysaccharides (Cimanga et al., 1995,
Sang et al., 2003; Kamiya et al., 2004; Pawlus et al., 2005; Lin et al., 2007; Akisha et al.,
2007). Polysaccharides from Noni fruit have been reported to have immunomodulatory
properties in vitro (Hirazumi et al., 1996, 1999; Furusawa et al., 2003). Also, some
phytochemicals present in Noni fruit were shown to have immunomodulatory activity by
modulating NF-kB signal transduction pathway in a dose dependent manner (Desai et al.,
2009; Murakami et al., 2007).
In the present study, 4% dietary Noni supplement only increased the expression of
TLR-3. This response may be due to the effects of phytochemicals on the TLR-3 signal
transduction pathway, which uses interferon regulatory factor-3 (IRF-3) transcription
factor to express antiviral products, in contrast to other TLRs that signal via the NF-kB
transcription factor (Akira et al., 2004). This is supported by the fact that some
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phytochemicals like quercetin which is present in the Noni fruit, stimulate the production
of interferon-γ (IFN-γ) an antiviral product (Park et al., 2009). IFN-γ then acts in an
autocrine manner and provides positive feedback for expression of TLR-3 via the JAK
STAT pathway (Tanabe et al., 2003; Tohyama et al., 2005). However, at higher
concentrations of phytochemicals, these might inhibit the expression of TLR-3 due to
excessive production of IFN-γ which provides a negative feedback for TLR-3 gene
expression (Dai et al., 2006). IFN-γ inhibition is due to production of SOCS (suppressors
of cytokine signaling) which inhibits the signaling of IFN-γ via the JAK STAT pathway.
The flavonoid, luteolin, also present in Noni fruit, suppresses the expression of interferon
regulatory factor-3 at least at higher concentrations (50 µM). This might be another
mechanism by which Noni suppresses gene expression of TLR-3 (Lee et al., 2009). In
the present study, the increased TLR-3 gene expression did not show any effect on
measured cytokines and chemokine gene expression. This lack of response may be
explained by the fact that neither TLR-4 nor TLR-5 were increased, and the increased
then TLRs modulate the expression of cytokines (Schaefer et al., 2004)
Noni at 6% increased 2.6 and 2.3 fold gene expression of Toll-like receptor-4 and
-5, respectively but decreased the TLR-7 gene expression (Figure 4.4). These TLRs all
share the common NF-kB pathways for gene expression. The increased expression of IL8 and IL-12 suggest that Noni polysaccharides bind to the TLR-4 at cell surface, since
plant polysaccharides cannot enter cells. Also, Han et al. (2002, 2003) shown that
polysaccharides bind with TLR-2 and -4 on the surface of immune cells and stimulate
production of various cytokines and chemokines by the NF-kB pathway. This is further
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supported by the findings that several polysaccharides isolated from plants have been
shown to have immunostimulatory activities (Kim et al., 1996; Han et al., 1998). The
activation of TLR-4 leads to its increased expression by both transcriptional and
posttranslational mechanisms (Muzio et al., 2000; Yan et al., 2006). Stimulation of TLR4 gene expression enhances expression of various proinflammatory cytokines and
chemokine, including IL-12 and IL-8 in human mast cells and in broilers heterophils
(Ferdous et al., 2008; Kirshenbaum et al., 2008). The results of this study agree with
those findings. Our observed increased TLR-5 gene expression might be possibly due to
the enhanced levels of cytokines.
Reduced IL-6 gene expression might be one contributing factor for reduced TLR7 gene expression, since previous research has shown that IL-6 cytokine selectively
increased the TLR-7 gene expression in humans (Zarember et al., 2002). Decreased IL-6
expression might be associated with unaltered IL-1 gene expression, as IL-6 gene
expression is mainly induced by IL-1 and TNF-α (Benveniste et al., 1990; Miyazawa et
al., 1998). Interestingly, both IL-1 and TNF-α were decreased in a graded manner when
dietary Noni treatment increased from 4 to 6%. Also, the location of TLR-7 on internal
cellular endosomes might limit its stimulation by Noni polysaccharides, as they can not
enter through the cell. In contrast, a number of phytochemicals that are present in Noni
can easily enter the cell. These might inhibit the basal expression level of TLR-7 and IL6. At the molecular level, the basal expression of TLR-7 and IL-6 is negatively regulated
by SOCS, phosphatases, and some other inhibitory enzymes, any of which might be
stimulated by Noni phytochemicals. Interestingly, in contrast to mammals, TLR-7 in
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chicken is not able to induce type I interferon in chicken and seems less important in viral
infection (Philbin et al., 2005).
In conclusion, the selectively increased TLR-3, TLR-4 and TLR-5 indicate that
Noni fruit induces antiviral and antibacterial responses in chickens which is further
strengthened by increased expression of IL-12 and IL-8 (Philbin et al., 2005). At the
same time, decreased expression of TLR-7 and IL-6 indicated anti-inflammatory
properties of Noni. Further investigations will be necessary to explore the active
immunomodulatory ingredients of Noni and its effects during viral and bacterial
infections.
Noni at 4% and 6% could increase the concentration of serum IgG and IgM
immunoglobulins. However, our lack of observing a significant effect might be due to the
contribution of natural antibodies (NAb) on the total measured IgG or IgM. The NAb
level against different or same antigens is affected by the linkage between the geneenvironment interactions, and different genetic origins of breeds, strains, and lines of
chickens (Van der Zijpp et. al., 1983; Kundu et al., 1999; Parmentier et al., 2004,
Hangalapura et al., 2003, Siwek et al., 2006). However it is assumed that broilers are
genetically similar due to selective line breeding but polygenic inheritance may be
associated to natural antibody response against antigen in chicken (Siwek et al., 2006)
and thus the interaction between more than two genes lead to the differences in natural
antibody concentration among broilers.
Further investigation is necessary to examine the effect of Noni using genetically
uniform lines, or strains with reduced genetic variation with increased number of sample
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size in order to extend the observation of apparent antiviral/antibacterial properties by
Noni after vaccination.
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Appendix A
Extraction of IgA Antibody from Chicken Gut Tissue
Materials required:
1. Phosphate buffer saline tablet (Sigma-Aldrich, P4417) 0.01 M phosphate buffer,
pH 7.4.
2. Trypsin inhibitor (Sigma-Aldrich, T-9003) @100 µg/ml in PBS.
3. Glass beads of 1 mm diameter (Biospec Product Inc. 11079110).
4. Centrifuge (Beckman- Coulter Microcentifuge 22R).
Procedure:
1. Dissolve one tablet of phosphate buffered saline in 200 ml of distilled water to
obtain 0.01 M phosphate buffer saline. Trypsin inhibitor is added to PBS @ 100
µg/ml.
2. Weigh whole frozen intestinal tissue and its content as quick as possible to avoid
thawing.
3. Put Intestine tissue along with its content into 1.5 ml plastic vial. Add 1 ml of
trypsin inhibited phosphate buffer saline into the vial and bring to final volume
with glass beads. Tightly cap the vial and make sure there are no bubbles present.
4. Homogenize the tissues in bead beater at 4800 rpm for 3 minutes. The
homogenate gets warm after 3 minutes. To minimize heating during the extraction
treatment prechill beads and buffer and stop for 60 seconds after each 60 seconds
blending. Immediately place homogenates on ice.
5. Decant homogenate or remove by pipetting after the beads settle to the bottom
and transfer into the 1.5 ml high “g”micro centrifuge tubes.
6. Centrifuge homogenate at 14000 X g for 10 minutes at 4 0C.
7. Remove the supernatant from the pellet and discard the pellet.
8. Store the supernatant at -80 0C until further analysis.
Source: Haghighi, H. R., Gong, J., Gyles, C.L., Hayes, M.A., Sanei, B., Parvizi, P., Haris, G.,
J.R. Chamber and S. Sharif (2005). Modulation of antibody- mediated immune response by
probiotics in chickens. Clinical and Diagnostic Laboratory Immunology 12: 1387-1392
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Appendix B
Collection of Tissue for RNA Extraction
Introduction:
RNases are present in cells and even the surrounding environment. They do not require a
cofactor to cleave the RNA in a non-specific or specific manner. However, tissue RNA
can be degraded by other non-specific mechanism, if samples are not stored properly. To
prevent degradation of RNA, samples must be preserved either by storage at very low
temperature (-800 C), in stabilizing reagents (RNAlater, Qiagen Inc.), or using a
combination of both.
Materials required
1. Sterilized 5 ml RNA free collection vials
2. Sterilized scissors
3. Sterilized forceps
4. Concentrated EtOH (95%)
5. Test tube stand
6. Permanent markers
7. RNAlater RNA stabilization reagent
8. Insulator box with ice
9. Gloves
10. Sterilized syringe/droppers
11. Sterilized normal saline solution
12. Beaker 500 ml capacity (autoclaved and treated with 0.1% diethylpyrocarbonate
water)
13. Analytical balance
Things to be considered before collection of tissue
 RNAlater RNA stabilization reagent may form a precipitate during storage below
room temperature (15-250 C). Before using the RNAlater RNA stabilization
reagent, redissolve the precipitate by heating to 370 C with agitation.
 Only fresh unfrozen tissue can be stabilized using RNAlater RNA stabilization
reagent.
 Amount of reagent needed per sample: Around 180-250 mg samples need
approximately 2.5 ml of RNAlater RNA stabilization reagent.
 Storage container should be wide enough so that the reagent covers the entire
tissue.
 The procedures for tissue harvesting and RNA stabilization should be carried out
as quickly as possible.
 Sample must be cut into slices less than 0.5 cm thick and immediately put in to
the stabilization reagent (If the slices are thicker than 0.5 cm the reagent will
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diffuse too slowly into the interior of the sample and RNA degradation will
occur).
Protocol for collection of tissue:
1. Sterilize work area and instruments with 70% EtOH.
2. Treat glass vials with 0.1% DEPC to eliminate RNAase. Pipette 10 x (estimated
tissue mass) RNAlater RNA stabilization reagent into each vial and cap the vials.
3. Collect tissue, take a suitable mass of sample, chop and place in vial with
stabilization reagent. Make sure the level of stabilization reagent is well above the
tissue.
4. Place vials overnight at 2-80 C, then store at -200 C.
Precaution:
1. Preparation of normal saline (0.89% W/V) in sterile water (water must be
autoclaved and 0.1% diethylpyrocarbonate treated).
2. Collection vials should be RNase free. Use glass vials and make them RNase free
by 0.1% diethylpyrocarbonate treatment.
3. If transporting tissue samples in RNAlater reagent, ensure that the tissue always
remains submerged in the reagent. Either keep the tubes upright during transport
or fill the tubes completely with RNAlater reagent.
4. Stored tissue can be thawed at room temperature and frozen again for up to 20
freeze-thaw cycles without affecting RNA quality or yield.
Source:
QIAGEN RNeasy® Mini Handbook, 4th edition (2006).

50

Appendix C
Extraction of Total RNA
Introduction:
Biological samples are first lysed and homogenized in the presence of a highly
denaturing guanidine-thiocyanate-containing buffer, which immediately inactivates
RNases to ensure purification of intact RNA. Ethanol is added to provide appropriate
binding conditions, and the sample is then applied to an RNeasy mini spin column. The
total RNA binds to the membrane and contaminants are efficiently washed away. Highquality RNA is then eluted in 50 μl water.
Materials required:
Qiagen RNeasy® protect mini kit with required buffers (RLT, RPE, RW1 and RDD)
2 ml RNase free polypropylene tubes
Disposable blades
Pestle and mortar
Micropipettes / RNase free tips
Liquid nitrogen
Ethanol (96-100% and 70%)
Centrifuge
QIAshredder columns
RNase-free DNase set
Glass vials
Thermocol box with ice (for maintain the temperature during the DNase preparation)
Things to do before starting experiment:
 Buffer RLT is prepared by adding 10 microliters of mercaptoethanol per 1 ml of
RLT. It can be stored at room temperature for up to 1 month.
 Before using for the first time, add 4 volumes of ethanol (96-100%) in
concentrated buffer RPE as indicated to obtain a working solution.
 70% ethanol is prepared using RNase free water.
 DNase digest buffer is prepared by adding lyophilized DNase in buffer RDD.
Protocol:
1. Remove RNAlater stabilized tissue from the reagent using forceps and remove
any crystals that may have formed.
2. Weigh the piece to be used (20 mg) directly into microcentrifuge tube. If
necessary, cut tissue on a clean sterile surface with a sterile scalpel.
3. Immediately place the weighed tissue in liquid nitrogen and grind thoroughly with
a mortar and pestle. Decant tissue powder and liquid nitrogen into an RNase-free,
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liquid nitrogen-cooled, 2 ml microcentrifuge tube. Allow the liquid nitrogen to
evaporate, but do not allow the tissue to thaw.
4. Add 600 µl buffer RLT, vortex it and pipette the lysate directly into a
QIAshredder spin column placed in a 2 ml collection tube, and centrifuge for 2
minutes at full speed at room temperature.
5. Discard the QIA shredder column.
6. Centrifuge the lysate for 3 minutes at full speed. Carefully remove the supernatant
by pipetting and transfer it to a new microcentrifuge tube. Use only this
supernatant (lysate) in subsequent steps.
7. Add 1 volume of 70% ethanol to the cleared lysate and mix immediately by
pipetting. Do not centrifuge. Immediately proceed to step 8 (precipitate may be
visible after addition of ethanol. This does not affect the procedure)
8. Transfer up to 700 μl of the sample, including any precipitate that may have
formed, to an RNeasy spin column placed in a 2 ml collection tube (supplied by
Qiagen). Centrifuge for 15 s at 10,000 rpm. Discard the flow through. If the
sample volume exceeds 700 μl, centrifuge successive aliquots in the same RNeasy
spin column. Discard the flow-through after each centrifugation.
9. Add 350 μl of buffer RW1 to the RNeasy spin column and centrifuge for 15 s at
10,000 rpm to wash the spin column membrane. Discard the flow through. Retain
the collection tube for reuse in step 11.
10. Add 80 μl DNase I directly to the RNeasy spin column membrane, and place on
the bench top (for 15 minutes). Be sure to add the DNase I incubation mix directly
to the RNeasy spin column membrane. DNase digestion will be incomplete if part
of the mix sticks to the wall or the O-ring of the spin column.
11. Add 350 μl Buffer RW1 to the RNeasy spin column and centrifuge for 15 s at
more than or equal to 10,000 rpm. Discard the flow-through. Transfer RNeasy
column to a new 2 ml collection tube.
12. Add 500 µl of buffer RPE to the RNeasy spin column and centrifuge for 15 s at
10,000 rpm to wash the spin column membrane. Discard the flow through.
13. Add another 500 μl of buffer RPE to the RNeasy spin column and centrifuge for 2
minutes at 10,000 rpm to wash the spin column membrane.
14. Place column in a new 2 ml collection tube and discard the flow through after
centrifugation for 1 minute.
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15. Transfer column to a new 1.5 ml collection tube (supplied in kit). Add 50 μl of
RNase free water directly onto the column and keep it for 1 minute at room
temperature. Close tube and centrifuge at 10,000 rpm for 1 minute to elute.
Source:
QIAGEN RNeasy® Mini Handbook, 4th edition (2006).
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Appendix D
Conversion of mRNA to cDNA and Amplification of cDNA
Introduction:
Use of the QuantiTect SYBR Green RT-PCR master mix containing reverse transcriptase
together with the QuantiTect RT Mix containing DNA polymerase allow both reverse
transcription and amplification of transcript in a single tube.
Material required:
QuantiTect SYBR Green RT-PCR Kit
Primers
96 well plates for the reactions
Plate covers
Ice box with ice
RNase free water
Pipettes: 2 µl, 20 μl, 200 µl and 1000 μl
RNase free tips for measurements
Real time cycler
Extracted RNA
RNase free water
Gloves
Sterile 1.5 ml of centrifuge tubes
Things to do before starting:






Adjust the RNA concentration in RNase free water in such a manner that all RNA
concentration must be equal to 10 ng per 10 µl of volume.
Calculate the amount of master mix needed for the reactions according to Table 1.
Multiply the individual volumes with number of samples.
Make the PCR plate template and set temperature and time program in the
computer software attached with thermocycler day before planning to run
samples. Check the direction of putting PCR plate in the Real time cycler.
Thawing should be performed at ice temperature.
Dilute the final concentration of primer to 0.5 μM in RNase free water.

Protocol:
1. Thaw 2x QuantiTect SYBR Green RT-PCR Master Mix (if stored at -200 C), template
RNA, primers, and RNase- free water at ice. Mix the individual solutions, and place them
on ice. The QuantiTect RT Mix should be taken from -200 C immediately before use,
always kept on ice, and returned to storage at -200 C immediately after use.

54

Table 1: Different volumes of 25 μl reaction mixture.
Component
2x QuantiTect SYBR Green
RT-PCR Master Mix
Primer forward
Primer backward
QuantiTect RT Mix
RNase- free water
Template RNA ( added at
step 5)
Total volume

Volume/reaction
12.5 μl

Concentration

0.5 μl
0.5 μl
0.25 μl
1.25
10 μl

0.5 μM
0.5 μM
0.25 μl / reaction
1ng/ μl

25 μl

2. Vortex the Primers and master mix, and mix the RT solution by gentle tapping. Do not
centrifuge any of them.
3. Each mixed component is then dispensed in 96 well PCR plate as following order and
final volume adjusted to 25 µl with RNase free water:
A. RNase free water
B. master mix
C. RT (reverse transcriptase)
4. Add template RNA to the individual PCR wells containing reaction mixture . This may
be done prior to step 3.
5. Seal the plate with sealer
6. Program the Real time cycler according to the program outlined :
One cycle of
 50 0C for 30 minutes (Reverse transcription)
 950 C for 15 minutes (DNA polymerase is activated, reverse transcriptases are
deactivated and template cDNA is denatured)
Followed by 40 cycles of
 940 C for 15 seconds (Denaturation)
 570 C for 20 seconds (anneling)
 720 C for 20 seconds (extension)
7. Data acquisition should be performed during the extension step.
8. Keep samples on ice until the Real time cycler is programmed. Place the PCR tubes or
plates in the thermal cycler and start the cycling program.
Source:
Qiagen kit manual for quantitative, real time, one step RT-PCR, November, 2000
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Appendix E
Conversion of mRNA to cDNA and Amplification of cDNA for Gel Electrophoresis
Introduction:
Reverse transcriptase is used to convert the mRNA to cDNA using oligo dT primers. The
resulting cDNA are amplified using specific primers for the specific gene expression in
separate tube.
Material required:
Protoscript ® II RT-PCR Kit
Primers
Polyacrylamide gel 1.5%
Camera
Illuminometer
PCR tubes
100 bp Ladder Aluminium foil
Ice box
RNase free water (DEPC treated water)
Dye (Ethidium bromide)
6X loading dye
Thermocycler
First Strand cDNA Synthesis:
Proper precautions should be used to avoid ribonuclease contamination. This includes the
use of autoclaved tubes, baked glassware, ultra-pure solutions, sterile pipette tips and
latex gloves during manipulations
1. Thaw system components and place on ice. The 10X RT Buffer can be warmed briefly
at 42°C and vortexed to dissolve any precipitate. (Note: It is important to set up a -RT
control reaction (no reverse transcriptase) to insure there is no DNA contamination).
2. Make the RNA/primer/dNTP mix by combining the following components in a PCR
tube:
Total RNA
: 1–10 μl (2 μg)
: 2 μl
Primer dT23VN
dNTP Mix
: 4 μl
Nuclease-free water : variable
Total volume
: 16 μl
3. Heat for 5 minutes at 70°C. Spin briefly and promptly chill on ice.
4. Add the following components to the 16 μl RNA/primer/dNTP solution and mix well
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by pipetting up and down:
10X RT Buffer
RNase Inhibitor
Reverse Transcriptase
Nuclease-free water
Final volume

- RT control
2 μl
0.5 µl
–
1.5 µl
20 µl

2 μl
0.5 µl
1 µl
0.5 µl
20 μl

4. Incubate the 20 μl cDNA synthesis reaction mixture at 42°C for one hour.
5. Inactivate the enzyme at 80°C for 5 minutes.
6. Bring the reaction volume to 50 μl with water. The cDNA product should be stored at
–20°C.
PCR Amplification:
1. Mix the following in a PCR tube on ice:
Taq 2X Master Mix
25 μl (mix well by inverting before use)
Forward Primer (10 μM)
1 μl (final concentration 200 nm)
Reverse Primer (10 μM)
1 μl (final concentration 200 nm)
Diluted cDNA
2.5 or variables
H20 variable
20.5 or variables
Total volume
50 µl
2. Mix gently and allowed the reaction to proceed under the following condition:
Initial denaturation
35-40 Cycles
Final Extension

95°C
94°C
57°C
68°C
68°C

1 minute
30 seconds
30 seconds
1 minute per kb
10 minutes

3. Optimize cycle numbers to prevent the amount of PCR product from exceeding the
upward slope of a typical cycle number-PCR product. Apply 35 cycles for IL-8 and
TLR-7 assays and 40 cycles for IL-12 assay.
Quantification:
1. Separate gene specific PCR products in 1.5% agarose gels using 0.02% ethidium
bromide for visualization.
2. Quantify band intensity in ultraviolet light using illuminometer and Image J software
(www.rsb.info.nih.gov). Target gene is expressed relative to the internal control
(GAPDH).
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Source:
Protoscript® M-MuLV Taq RT-PCR kit instructional manual, New England Biolabs Inc.,
MA
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Appendix F
Primer Sequences
Direction
Forward
IL-1β
Backward
Forward
IL-6
Backward
Forward
IL-8
Backward
Forward
IL-12
Backward
Forward
TLR-3
Backward
Forward
TLR-4
Backward
Forward
TLR-5
Backward
Forward
TLR-7
Backward
Forward
GAPDH
Backward
Genes

*Primer sequences (5’-3’)
GCTCTACATGTCGTGTGTGATGAG
TGTCGATGTCCCGCATGA
ATGTGCAAGAAGTTCACCGTGTGC
TTCCAGGTAGGTCTGAAAGGCGAA
TTTCAGCTGCTCTGTCGCAAGGTA
CTTGGCGTCAGCTTCACATCTTGA
TGTCTCACCTGCTATTTGCCTTAC
CATACACATTCTCTCTAAGTTTCCACTGT
ACCCGGATTGCAGTCTCAGTACAT
TGTCCTTGCAGGCTGAGGTATCAA
GTTGCTTGCTGCAGGAGTGTTTCT
AGGGTTCCACCAGCTCTTTCATCA
TGAACTCCAGCAGACACTCAGGTT
TGCAGGTGGATGGCTTCCTATCAA
ATCTGACGGTGTTGGATCTTGGGA
ACGTGCCTGCTGTATTGCTCTACT
ATGCCATCACAGCCACACAGAAGA
GCACACGGAAAGCCATTCCAGTAA

Accession no.
Y15006
AJ309540
DQ393272
NM_213571
NM_001011691
AY064697
NM_001024586
FJ915600
NM_204305

Product size (bp)
75
171
127
87
92
179
160
187
171

* Primers were designed using PrimerQuest software (www.idtdna.com, integrated DNA Technology, Iowa)
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